HomeCompareCLRD vs MRK

CLRD vs MRK: Dividend Comparison 2026

CLRD yields 181818.18% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLRD wins by $1.8951031795759825e+29M in total portfolio value
10 years
CLRD
CLRD
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full CLRD calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CLRD vs MRK

📍 CLRD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLRDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLRD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLRD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLRD
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CLRD beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLRD + MRK for your $10,000?

CLRD: 50%MRK: 50%
100% MRK50/50100% CLRD
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CLRD
No analyst data
Altman Z
-19.2
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLRD buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLRDMRK
Forward yield181818.18%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.8951031795759825e+29M$57.7K
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00$10,113.78
Total dividends collected$1.8949690612486723e+29M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLRD vs MRK ($10,000, DRIP)

YearCLRD PortfolioCLRD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,192,518$18,181,818.18$11,213$373.04+$18.18MCLRD
2$30,932,835,887$30,913,369,892.64$12,667$512.06+$30932.82MCLRD
3$49,156,619,660,049$49,123,521,525,649.34$14,439$708.14+$49156619.65MCLRD
4$73,009,768,971,452,110$72,957,171,388,415,860.00$16,640$988.16+$73009768971.44MCLRD
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$19,432$1,394.07+$101348671691011.75MCLRD
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$23,057$1,992.90+$131490628941834960.00MCLRD
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$27,889$2,894.79+$159445709700484431872.00MCLRD
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$34,518$4,286.29+$1.8070656065589233e+23MCLRD
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$43,912$6,494.35+$1.9141674430419936e+26MCLRD
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$57,714$10,113.78+$1.8951031795759825e+29MCLRD

CLRD vs MRK: Complete Analysis 2026

CLRDStock

Clearday, Inc. operates as a non-acute longevity health care services company. The company operates residential memory care communities in four U.S. states. It offers Clearday at Home, a digital service that connects the senior and their loved ones with proprietary programing that includes a range of activities, including physical and mental exercises; Clearday Network, a subscription service that helps agencies recruit and retain caregivers and enhance client experiences, as well as provides support and backbone to Clearday services; and Clearday Clubs, a membership-based adult day care model that provides daytime-only care primarily for individuals with Alzheimer's disease, other dementias, or other lifestyle-limiting chronic health conditions. The company also provides Clearday Restore, a sensory therapy that combines light, sound, and aromas designed to reduce anxieties; and Clearday Therapeutic Streams that provides guidance to care givers. Clearday, Inc. was incorporated in 1987 and is headquartered in San Antonio, Texas.

Full CLRD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CLRD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLRD vs SCHDCLRD vs JEPICLRD vs OCLRD vs KOCLRD vs MAINCLRD vs JNJCLRD vs ABBVCLRD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.